188 related articles for article (PubMed ID: 16642238)
1. Life after breast cancer.
Stuart K; Brennan M; French J; Houssami N; Boyages J
Aust Fam Physician; 2006 Apr; 35(4):219-24. PubMed ID: 16642238
[TBL] [Abstract][Full Text] [Related]
2. Follow-up care in breast cancer.
Rutgers EJ
Expert Rev Anticancer Ther; 2004 Apr; 4(2):212-8. PubMed ID: 15056051
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer: initial diagnosis and current treatment options.
Judkins AF; Akins J
Nurs Clin North Am; 2001 Sep; 36(3):527-42, xi. PubMed ID: 11532667
[TBL] [Abstract][Full Text] [Related]
4. Hormonal breast cancer agents: implications for the primary care provider.
Lyon DE; Roux G; Voll S
J Am Acad Nurse Pract; 2006 Nov; 18(11):518-23. PubMed ID: 17064329
[TBL] [Abstract][Full Text] [Related]
5. Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer.
Owusu C; Buist DS; Field TS; Lash TL; Thwin SS; Geiger AM; Quinn VP; Frost F; Prout M; Yood MU; Wei F; Silliman RA
J Clin Oncol; 2008 Feb; 26(4):549-55. PubMed ID: 18071188
[TBL] [Abstract][Full Text] [Related]
6. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
[TBL] [Abstract][Full Text] [Related]
7. Locally advanced and inflammatory breast cancer.
Ahern V; Brennan M; Ung O; Kefford R
Aust Fam Physician; 2005 Dec; 34(12):1027-32. PubMed ID: 16333485
[TBL] [Abstract][Full Text] [Related]
8. Metastatic breast cancer.
Stevanovic A; Lee P; Wilcken N
Aust Fam Physician; 2006 May; 35(5):309-12. PubMed ID: 16680209
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
Honma N; Horii R; Iwase T; Saji S; Younes M; Takubo K; Matsuura M; Ito Y; Akiyama F; Sakamoto G
J Clin Oncol; 2008 Aug; 26(22):3727-34. PubMed ID: 18669459
[TBL] [Abstract][Full Text] [Related]
10. [Monitoring of patients with breast cancer after multimodal treatment].
Prieto MM; de la Torre CB; Basurto CS; Forgach ES
Ginecol Obstet Mex; 2008 Feb; 76(2):107-12. PubMed ID: 18798403
[TBL] [Abstract][Full Text] [Related]
11. Recurrences and second primary breast cancers in older women with initial early-stage disease.
Geiger AM; Thwin SS; Lash TL; Buist DS; Prout MN; Wei F; Field TS; Ulcickas Yood M; Frost FJ; Enger SM; Silliman RA
Cancer; 2007 Mar; 109(5):966-74. PubMed ID: 17243096
[TBL] [Abstract][Full Text] [Related]
12. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
Kennecke H; McArthur H; Olivotto IA; Speers C; Bajdik C; Chia SK; Ellard S; Norris B; Hayes M; Barnett J; Gelmon KA
Cancer; 2008 Apr; 112(7):1437-44. PubMed ID: 18286526
[TBL] [Abstract][Full Text] [Related]
13. Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
Rondanina G; Puntoni M; Severi G; Varricchio C; Zunino A; Feroce I; Bonanni B; Decensi A
J Clin Oncol; 2008 Mar; 26(9):1537-43. PubMed ID: 18349406
[TBL] [Abstract][Full Text] [Related]
14. [A woman with a disappearing breast].
Bech AP; Mattijssen EJ
Ned Tijdschr Geneeskd; 2011; 155(50):A4077. PubMed ID: 22186367
[TBL] [Abstract][Full Text] [Related]
15. [Surveillance of a woman treated for breast cancer].
Lansac J; Diouf A
Rev Prat; 1998 Jan; 48(1):71-6. PubMed ID: 9781213
[TBL] [Abstract][Full Text] [Related]
16. The value of routine physical examination in the follow up of women with a history of early breast cancer.
Lu W; de Bock GH; Schaapveld M; Baas PC; Wiggers T; Jansen L
Eur J Cancer; 2011 Mar; 47(5):676-82. PubMed ID: 21130643
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant treatment of breast cancer. Endocrine therapy].
Mouridsen HT; Andersen J
Ugeskr Laeger; 2007 Sep; 169(37):3072-6. PubMed ID: 17877951
[TBL] [Abstract][Full Text] [Related]
18. Advantages of multiple clinical tests for determining the optimum treatment strategy for ER-positive breast cancer.
Ditzel HJ; Lyng MB
Nat Clin Pract Oncol; 2008 Jul; 5(7):376-7. PubMed ID: 18506164
[No Abstract] [Full Text] [Related]
19. [Follow-up care in breast carcinoma].
Wandt H; Bruntsch U; Gallmeier WM
Dtsch Med Wochenschr; 1989 Jul; 114(28-29):1130-6. PubMed ID: 2743878
[No Abstract] [Full Text] [Related]
20. Tamoxifen in ductal carcinoma in situ.
Daly MB
Semin Oncol; 2006 Dec; 33(6):647-9. PubMed ID: 17145343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
